New Alzheimer's drug slows disease by a third

Indonesia Berita Berita

New Alzheimer's drug slows disease by a third
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 bbchealth
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 63%

The second such drug in a year raises hopes we can start treating dementia.

We could be entering the era of Alzheimer's treatments, after the second drug in under a year has been shown to slow the disease.

Amyloid builds up in the spaces between brain cells, forming distinctive plaques that are one of the hallmarks of Alzheimer's. The full details of Eli Lilly's trial have yet to be published - but it has revealed the key findings:Donanemab was given as a monthly infusion until the distinctive plaques in the brain were gone

"We are encouraged by the potential clinical benefits that donanemab may provide, although like many effective treatments for debilitating and fatal diseases, there are associated risks that may be serious and life-threatening," Eli Lilly group vice-president of neuroscience research and development Dr Mark Mintun said.

"This should dispel any lingering doubts about this approach," Prof John Hardy, from the UK Dementia Research Institute, whose work led to the idea of targeting amyloid, 30 years ago, said. "Having two drugs is great for competition."

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

bbchealth /  🏆 143. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Experimental Drug Slows Alzheimer’s in Large Study, Eli Lilly SaysExperimental Drug Slows Alzheimer’s in Large Study, Eli Lilly SaysAn experimental Eli Lilly drug slowed cognitive and functional decline for people with early-stage Alzheimer’s disease in a new study that could support regulatory approval and commercial sale
Baca lebih lajut »

Eli Lilly's Alzheimer's drug donanemab slows cognitive decline: trialAn experimental drug just showed it can help slow Alzheimer's, offering new hope for patients and a major boost to pharma giant Eli Lilly
Baca lebih lajut »

New Ph.D. program in autism could help spur new researchNew Ph.D. program in autism could help spur new researchA program is working to bring together different facets of autism specialization into one setting, as data shows 1 in 36 children are on the spectrum.
Baca lebih lajut »

New York City's new tool to stop car thefts: Apple AirTagsNew York City's new tool to stop car thefts: Apple AirTagsWith car thefts soaring to a 16-year high, the city is distributing 500 of the devices 'to take a bad guy off the streets,' NYPD says.
Baca lebih lajut »

'The Real Housewives of New York City' Returns: See the New Teaser'The Real Housewives of New York City' Returns: See the New TeaserThe Housewives are back to take a bite out of the Big Apple.
Baca lebih lajut »

New Yorkers give low marks to city’s bike infrastructure in new ‘Cycling Census’ | amNewYorkNew Yorkers give low marks to city’s bike infrastructure in new ‘Cycling Census’ | amNewYorkThe city’s bicycling infrastructure has plenty of room for improvement, according to thousands of cyclists who responded to the first-ever New York Cycling Census.
Baca lebih lajut »



Render Time: 2025-03-01 02:16:57